|
|
Blood, 1 August 2005, Vol. 106, No. 3, pp. 1105-1112.
Prepublished online as a Blood First Edition Paper on April 14, 2005; DOI 10.1182/blood-2005-03-1040.
Previous Article | Table of Contents | Next Article 
TRANSFUSION MEDICINE
Nonhemolytic antibody-induced loss of erythrocyte surface antigen
James C. Zimring,
Gregory A. Hair,
Traci E. Chadwick,
Seema S. Deshpande,
Kimberly M. Anderson,
Christopher D. Hillyer, and
John D. Roback
From the Transfusion Medicine Program, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.
Transfusion of red blood cells (RBCs) into patients with antidonor RBC antibodies (crossmatch-incompatible transfusion) can result in lethal antibody-mediated hemolysis. Less well appreciated is the ability of anti-RBC antibodies to specifically remove their target antigen from donor RBCs without compromising cell survival or adversely affecting the transfusion recipient. In an effort to elucidate the mechanistic details of this process, we describe the first animal model of nonhemolytic antibody-induced RBC antigen loss. RBCs from transgenic mHEL mice express surface hen egg lysozyme (HEL) as a transmembrane protein. Transfusion of mHEL RBCs into mice immunized with HEL results in selective loss of HEL antigen from donor RBCs without affecting other blood group antigens or reducing the circulatory life span of the transfused RBCs. While this process does not require the presence of a spleen, it requires both anti-RBC immunoglobulin G (IgG) antibodies and the Fc III receptor. These studies provide mechanistic insight into the phenomenon of antigen loss during incompatible transfusion in humans.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Yin and yang in transfusion medicine
- Steven L. Spitalnik
Blood 2005 106: 771-772.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. E. Hendrickson, T. E. Chadwick, J. D. Roback, C. D. Hillyer, and J. C. Zimring
Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells
Blood,
October 1, 2007;
110(7):
2736 - 2743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Zimring, C. M. Cadwell, T. E. Chadwick, S. L. Spitalnik, D. A. Schirmer, T. Wu, C. A. Parkos, and C. D. Hillyer
Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes
Blood,
September 15, 2007;
110(6):
2201 - 2208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Powers, M. Mohammed, L. Uhl, and R. L. Haspel
Apparent nonhemolytic alloantibody-induced red-cell antigen loss from transfused erythrocytes
Blood,
May 15, 2007;
109(10):
4590 - 4590.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Schirmer, S.-C. Song, J. P. Baliff, S. O. Harbers, R. A. Clynes, A. Krop-Watorek, G. R. Halverson, M. Czerwinski, and S. L. Spitalnik
Mouse models of IgG- and IgM-mediated hemolysis
Blood,
April 1, 2007;
109(7):
3099 - 3107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Williams, J. J. Densmore, A. W. Pawluczkowycz, P. V. Beum, A. D. Kennedy, M. A. Lindorfer, S. H. Hamil, J. C. Eggleton, and R. P. Taylor
Thrice-Weekly Low-Dose Rituximab Decreases CD20 Loss via Shaving and Promotes Enhanced Targeting in Chronic Lymphocytic Leukemia
J. Immunol.,
November 15, 2006;
177(10):
7435 - 7443.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|